文献速递垂体与肾上腺疾病

原发性醛固酮增多症患者动脉僵硬与长期主要不良心脏事件相关

Arterial Stiffness Associated With Long-term Major Adverse Cardiac Events in Patients With Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究纳入830例原发性醛固酮增多症患者,中位随访5.8年,113例(13.6%)发生主要不良心血管事件,粗发生率23.2/1000人年。多变量Cox分析显示baPWV是主要不良心血管事件的独立危险因素(校正HR=1.01,P=.028),baPWV≥2000 cm/s者风险更高(HR=1.81,P=.024);盐皮质激素受体拮抗剂使用者且baPWV高者风险显著升高(HR=3.34,P<.001),而肾上腺切除术者风险不显著(P=.062)。

要点

  • 原发性醛固酮增多症患者中位随访5.8年,13.6%发生主要不良心血管事件。
  • baPWV是主要不良心血管事件的独立危险因素,切点2000 cm/s者HR=1.81。
  • 盐皮质激素受体拮抗剂使用者且baPWV高者HR=3.34,肾上腺切除术者风险不显著。

核心结论

  • 本研究发现原发性醛固酮增多症患者中位随访5.8年后13.6%发生主要不良心血管事件。
  • baPWV可能作为原发性醛固酮增多症一级预防中风险分层的工具,而肾上腺切除术似乎可减轻该风险 regardless of baPWV。
  • baPWV测量可能成为高血压筛查项目中有价值的补充,为原发性预防中主要不良心血管事件的发生提供额外预测信息。

研究设计与样本

  • 一级预防设计,纳入830例原发性醛固酮增多症患者进行最终分析。
  • 中位随访5.8年,观察主要不良心血管事件发生。

主要发现

  • 113例(13.6%)发生主要不良心血管事件,粗发生率23.2/1000人年。
  • 多变量Cox比例风险分析显示baPWV是主要不良心血管事件的独立危险因素,校正HR=1.01(P=.028)。
  • 广义相加模型确定baPWV切点值为2000 cm/s,独立关联主要不良心血管事件,HR=1.81(P=.024),并考虑死亡作为竞争风险。
  • 亚组分析显示盐皮质激素受体拮抗剂使用者且baPWV高的原发性醛固酮增多症患者主要不良心血管事件风险显著更高(HR=3.34,P<.001),而肾上腺切除术患者风险不显著(P=.062)。
  • 将baPWV加入心血管Framingham风险评分显著改善无类别净重分类指数(0.308,P<.001)。

临床怎么用

  • baPWV测量可能作为原发性醛固酮增多症一级预防中风险分层的工具。
  • baPWV测量可能成为高血压筛查项目中有价值的补充,为原发性预防中主要不良心血管事件的发生提供额外预测信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: As a novel parameter for risk prediction, artery stiffness may hold promise in refining risk assessment strategies, guiding therapeutic interventions, and ultimately improving cardiovascular outcomes in patients with primary aldosteronism (PA). OBJECTIVE AND METHODS: To investigate the correlation between brachial-ankle pulse wave velocity (baPWV), an indicator of arterial stiffness, and the occurrence of major adverse cardiovascular events (MACEs) in patients with PA under a primary prevention design. RESULTS: Among the 830 patients included in the final analysis, 113 (13.6%) developed incident MACEs over a median follow-up period of 5.8 years, with a crude rate of 23.2 per 1000 person-years. Multivariable Cox proportional hazards analyses revealed that baPWV was an independent risk factor for incident MACEs, with an adjusted hazard ratio (HR) of 1.01 (P = .028). The generalized additive model identified a cut-off value of 2000 cm/s for baPWV, which was independently associated with incident MACEs, with a HR of 1.81 (P = .024), while accounting for mortality as a competing risk. Subgroup analyses revealed that PA patients who were mineralocorticoid receptor antagonist users and had high baPWV had a significantly higher risk of incident MACEs (HR = 3.34; P < .001), whereas the risk was not significant in patients who underwent adrenalectomy (P = .062). Furthermore, the addition of baPWV to the cardiovascular Framingham risk score significantly improved the category-free net reclassification index (0.308, P < .001). CONCLUSIONS: Our study found that 13.6% of patients with PA developed MACEs after a median follow-up of 5.8 years. Our findings highlight the potential utility of baPWV as a tool for risk stratification in patients with PA in primary prevention, whereas adrenalectomy appears to mitigate this risk regardless of baPWV. The measurement of baPWV could be a valuable addition to hypertension screening programs for primary prevention, providing additional predictive information for the potential occurrence of MACEs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wu VC, Chu WK, Yang PL, et al. Arterial Stiffness Associated With Long-term Major Adverse Cardiac Events in Patients With Primary Aldosteronism. J Clin Endocrinol Metab. 2025. PMID: 39391904. doi:10.1210/clinem/dgae683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。